| Literature DB >> 16356583 |
Julien Massard1, Vlad Ratziu, Dominique Thabut, Joseph Moussalli, Pascal Lebray, Yves Benhamou, Thierry Poynard.
Abstract
Cirrhosis is the end-stage consequence of fibrosis progression in patients with chronic hepatitis C. The median time from infection to cirrhosis is 30 years, with a high inter-individual variability, which is now better understood. Several factors have been clearly shown to be associated with fibrosis progression rate: duration of infection, age, male gender, alcohol consumption, HIV co-infection and low CD4 count. Metabolic conditions such as steatosis, being overweight and diabetes are emerging as independent co-factors of fibrogenesis. The recent validation of non-invasive biomarkers should facilitate the study of fibrosis progression in large populations.Entities:
Mesh:
Year: 2005 PMID: 16356583 DOI: 10.1016/j.jhep.2005.11.009
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083